Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousBone Marrow TransplantationGraft vs Host DiseaseGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Blood Component RemovalMelphalanCombined Modality TherapyStem CellsHematologic NeoplasmsHematopoietic Stem CellsMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeBusulfanLymphoma, Non-HodgkinStem Cell TransplantationMyeloablative AgonistsGraft SurvivalThiotepaEtoposideAntineoplastic Agents, AlkylatingRemission InductionCytophagocytosisRecurrenceIfosfamideSalvage TherapyCarmustineHematopoiesisImmunosuppressive AgentsVincristineCord Blood Stem Cell TransplantationHodgkin DiseaseCytarabineNeoplasmsAmyloidosisBlood Cell CountRetrospective StudiesDisease-Free SurvivalTissue DonorsTime FactorsBlood CellsSurvival RateBone Marrow PurgingDoxorubicinLeukocytes, MononuclearWhole-Body IrradiationLymphoma, T-CellRecombinant ProteinsPlatelet CountCarboplatinSurvival AnalysisDexamethasoneEmbryonic Stem CellsCytomegalovirus InfectionsInfectionHistocompatibilityPrednisoneHistocompatibility TestingAdult Stem CellsTransplantation ChimeraAntineoplastic AgentsFlow CytometryFollow-Up StudiesCell SeparationProspective StudiesBlood Transfusion, AutologousLeukemia, Myeloid, AcuteT-LymphocytesImmunophenotypingLeukemiaCells, CulturedLymphomaBlood DonorsPluripotent Stem CellsFeasibility StudiesFatal OutcomeCell DifferentiationImmunomagnetic SeparationVidarabineOpportunistic InfectionsLymphocytesBone Marrow CellsStem Cell FactorFetal BloodHematologic DiseasesBone MarrowAnemia, AplasticStem Cell NicheBreast NeoplasmsFeverLeukocyte CountColony-Forming Units Assay